InSpace Accelerated Rehabilitation Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorStryker Endoscopy

About this trial

This is a prospective, parallel group, open-label, multi- center, randomized study to assess two accelerated rehabilitation programs for use with the InSpace device in the treatment of full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) performed during an arthroscopic procedure.

Eligibility criteria

Qualifiers

The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment

Is male or female ≥ sixty-five (65) years of age

Measuring ≥ 5 cm in diameter

Involving ≥ two tendons

Disqualifiers

Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)

Severe gleno-humeral or acromio-humeral arthritis

Full thickness cartilage loss as seen on MRI

History within the past 5 years of anterior or posterior shoulder subluxation or dislocation as determined by history, examination, or radiographic findings

Trial design

Treatments tested in this trial

  • InSpace Subacromial Tissue Spacer

Treatment groups

160 Participants
are divided into 2 treatment groups

Sponsors and collaborators